← Leaderboards
Ning Cheng
Univ Of North Carolina Chapel Hill
$452,898
Attributed
$452,898
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $100.6K · FY2017–22$200K$150K$100K$50K$0
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$452,898 · 2
By mechanism
K00$376,160 · 1
F99$76,738 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Jenny P.y. Ting$81,674,016
- Benjamin G Vincent$6,541,786
- Henry Shelton Earp$37,241,767
- Charles M Perou$46,508,459
- Eric Bachelder$2,970,795
Others in their field
Other Emerging Leaders on “Combined Modality Therapy”
- Barbara Burtness · Yale University$11,235,253
- Jurgen Bernd Bulitta · State University Of New York At Buffalo$7,090,719
- Kathleen N. Moore · University Of Oklahoma$6,686,608
- Nilu Goonetilleke · Univ Of North Carolina Chapel Hill$6,073,977
- Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru$5,834,007
- Nader Fotouhi · Global Alliance For Tb Drug Development$5,472,466
Research focus
Combined Modality TherapyControlled ReleaseAdaptive ImmunityClinical TrialsClinical PredictorsComplementAnticancer ResearchAdjuvant TherapyAgonistCessation Of LifeChemotherapyAreaBiologicalCancer GeneticsCancer ImmunotherapyCancer PatientCancer PreventionCancer TherapyCancer TypeCause Of DeathCd8-Positive T-LymphocytesCellsAdjuvantCtla4 Gene
Grant awards (7)
Modeling Primary Tumor Organoids for lmmunotherapy$100,561
K00 · FY2022 · CA · contact PI
Modeling Primary Tumor Organoids for lmmunotherapy$96,000
K00 · FY2021 · CA · contact PI
Modeling Primary Tumor Organoids for lmmunotherapy$61,412
K00 · FY2020 · CA · contact PI
Particulate Delivery of STING Agonist as Anti-cancer Immuotherapeutics and Cancer Microbiome$30,034
K00 · FY2020 · CA · contact PI
Particulate Delivery of STING Agonist as Anti-cancer Immuotherapeutics and Cancer Microbiome$88,153
K00 · FY2019 · CA · contact PI
Particulate Delivery of STING Agonist as Anti-cancer Immuotherapeutics and Cancer Microbiome$37,859
F99 · FY2018 · CA · contact PI
Particulate Delivery of STING Agonist as Anti-cancer Immuotherapeutics and Cancer Microbiome$38,879
F99 · FY2017 · CA · contact PI